3 unknown, 1 terminated, 1 withdrawn. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Unknown 3, Terminated 1, Withdrawn 1 |
Follow Pulmonary Aspergillosis: new trials by email Literature Review of Pulmonary Aspergillosis trials Research Report on Pulmonary Aspergillosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Benralizumab in the Treatment of Patients With Severe Asthma With ABPA Fasenra, 30 Mg/mL Subcutaneous Solution - ABPA, Severe Asthma | Phase 4 | Withdrawn | Baylor Research Institute | 2019-12-23 | 2022-02-01 | |
| Voriconazole for IPA in Chinese Patients With COPD Voriconazole - Invasive Pulmonary Aspergillosis, COPD | Phase 4 | Unknown | Red Cross Hospital, Hangzhou, China | 40 | 2014-10-01 | 2014-09-09 |
| Efficacy and Safety of Caspofungin for Invasive Pulmonary Aspergillosis Underlying Chronic Obstructive Pulmonary Disease caspofungin - Invasive Pulmonary Aspergillosis, Chronic Obstructive Pulmonary Disease | Phase 4 | Unknown | The First Affiliated Hospital of Guangzhou Medical University | 40 | 2012-01-01 | 2014-01-23 |
| An Exploratory Study to Assess Multiple Doses of Omalizumab in Patients With Cystic Fibrosis Complicated by Acute Bronchopulmonary Aspergillosis (ABPA) Omalizumab, Placebo, Itraconazole - Cystic Fibrosis, Allergic Bronchopulmonary Aspergillosis | Phase 4 | Terminated | Novartis Pharmaceuticals | 14 | 2008-11-01 | 2011-09-26 |
| Value of Amphotericin B Inhalation for Prophylaxis of Invasive Pulmonary Aspergillosis After Renal Transplantation Amphotericin B - Invasive Pulmonary Aspergillosis | Phase 4 | Unknown | Capital Medical University | 400 | 2008-06-01 | 2009-09-30 |
Invasive Pulmonary Aspergillosis (3) · Aspergillosis, Allergic Bronchopulmonary (2) · Pulmonary Disease, Chronic Obstructive (2) · Asthma (1) · Cystic Fibrosis (1)
Aspergillosis (5) · Bacterial Infections and Mycoses (5) · Infections (5) · Lung Diseases (5) · Lung Diseases, Fungal (5) · Mycoses (5) · Respiratory Tract Diseases (5) · Invasive Fungal Infections (3) · Lung Diseases, Obstructive (3) · Chronic Disease (2) · Disease Attributes (2) · Hypersensitivity (2) · Hypersensitivity, Immediate (2) · Immune System Diseases (2)
Amphotericin B (1) · Caspofungin (1) · Itraconazole (1) · Omalizumab (1) · Voriconazole (1) · benralizumab (1)
Baylor Research Institute (1) · Capital Medical University (1) · Novartis Pharmaceuticals (1) · Red Cross Hospital, Hangzhou, China (1) · The First Affiliated Hospital of Guangzhou Medical University (1)
China (3) · Belgium (1) · Germany (1) · Italy (1) · Netherlands (1) · United Kingdom (1) · United States (1)
Chuang Cai, doctor (1) · Feng Ye, MD (1) · Yolanda Mageto, MD (1)